Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Krystal Biotech, Inc.    KRYS

KRYSTAL BIOTECH, INC.

(KRYS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Sales - - - - 15,9 55,5
EBITDA -4,75 -11,8 -21,3 -36,7 -34,1 -28,6
Operating profit (EBIT) -4,77 -11,9 -22,1 -49,0 -54,2 -36,9
Pre-Tax Profit (EBT) -7,92 -10,9 -19,1 -48,3 -56,8 -41,7
Net income -7,90 -10,9 -19,1 -48,3 -56,8 -42,4
P/E ratio -7,11x -21,4x -46,2x -15,3x -13,7x -20,0x
EPS ( $ ) -1,48 -0,97 -1,20 -2,59 -2,89 -1,98
Dividend per Share ( $ ) - - - - - -
Yield - - - - - -
Reference price ( $ ) 10,520 20,780 55,380 39,580 39,580 39,580
Announcement Date 03/12/2018
12:00pm
03/12/2019
12:00pm
03/10/2020
12:03pm
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Debt - - - - - -
Finance 0,00 0,00 0,00 253 205 176
Operating income (EBITDA) -4,75 -11,8 -21,3 -36,7 -34,1 -28,6
Leverage
(Debt/EBITDA)
- - - - - -
Capital Expenditure - - - - 0,60 2,40
Free Cash Flow (FCF) - - - -38,5 -59,1 -53,3
Book Value Per Share (BVPS) (  ) - - - - - -
Cash Flow per Share (  ) - - - - - -
Announcement Date - - -
Balance Sheet Analysis
Financial data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2020e 2021e
Capitalization 687 M $ -
Entreprise Value (EV) 434 M $ 482 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) -15,3x -13,7x
Capitalization / Revenue - 43,2x
EV / Revenue - 27,3x
EV / EBITDA -11,8x -12,7x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) - -341%
Operating Leverage (Delta EBIT / Delta Sales) - -
Net Margin (Net Profit / Revenue) - -357%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   - 3,77%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend